Delivery Order SPE2DB22D2206-SPE2DB25FHM45
Award Date
6/17/25
Potential Completion Date
6/18/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,078.08, is a delivery order contract for the supply of dextroamphetamine-amphetamine 10 mg tablets. The contract has a firm fixed price and an ultimate completion date of February 20, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,262.20, is for the delivery of 4,566,953,985 units of the prescription drug Dextroamphetamine-Amphetamine 5 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of January 17, 2025. The award does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,243.38 firm fixed-price delivery order is for the supply of 4,568,254,602 tablets of the prescription medication dextroamphetamine-amphetamine 10 mg. The contract has an ultimate completion date of May 15, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,026.75, is for the delivery of 4,567,426,586 units of 20 mg dextroamphetamine-amphetamine tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 3, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566939633 dextroamphetamine-amphetamine 10 mg tablets, with a ceiling value of $1,077.60 and a completion date of January 16, 2025. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,533.79 firm-fixed-price delivery order is for the supply of dextroamphetamine-amphetamine 15 mg tablets, a prescription medication. The contract has an ultimate completion date of February 27, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,421,988 dextroamphetamine-amphetamine 10 mg tablets in 100-count bottles. The contract has a ceiling value of $1,053.12 and a completion date of March 3, 2025. It is a firm fixed-price delivery order contract type, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,515.75 firm fixed price delivery order is for the supply of 4,567,268,740 units of 5 mg dextroamphetamine-amphetamine tablets. The contract has an ultimate completion date of February 14, 2025 and was awarded on February 13, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,024.11, is for the delivery of dextroamphetamine-amphetamine 20 mg tablets in 100-count units. The contract is a Firm Fixed Price Delivery Order, with a period of performance through February 18, 2025. The contract is not designated with a set-aside requirement, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,307.98, is for the delivery of 10 mg dextroamphetamine-amphetamine tablets in 100-count bottles. The contract is a firm fixed-price delivery order with an ultimate completion date of April 2, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999...